Quieting Neuroinflammation Beyond energy metabolism, both pathways converge on neuroinflammation, the activation of the brain's resident immune cells, known as microglia, in response to stress, injury, or metabolic disruption
If manufacturing capacity is not secured early, programmes can stall even after successfully meeting clinical and device development milestones
A key pillar of this longevity strategy is metabolic health
Alzheimers Disease In Alzheimers disease models, GLP-1 RAs demonstrate multiple beneficial mechanisms, including reduced amyloid- and tau pathology through enhanced clearance mechanisms, decreased neuroinflammation by modulating microglial activation states, and enhanced synaptic plasticity through improved long-term potentiation and dendritic spine density [35,109]